SPAC6G9.01c Antibody

What is SPAC6G9.01c and why is it significant for research?

SPAC6G9.01c is a protein-coding gene found in Schizosaccharomyces pombe (fission yeast), a model organism widely used in molecular and cellular biology research. This gene and its protein product are significant for understanding fundamental cellular processes in eukaryotes. Antibodies targeting this protein enable researchers to study its expression, localization, and functional interactions in various cellular contexts. The significance stems from S. pombe's importance as a model organism that shares many genes with humans, making it valuable for studying conserved cellular mechanisms .

What types of SPAC6G9.01c antibodies are available for research applications?

Research applications typically utilize several types of SPAC6G9.01c antibodies, each with specific advantages:

These antibodies are produced using different technologies and can be selected based on experimental requirements and specific research questions .

How should SPAC6G9.01c antibodies be stored and handled for optimal performance?

For optimal performance and longevity, SPAC6G9.01c antibodies should be stored according to manufacturer specifications, typically at -20°C for long-term storage and 4°C for short-term use. Avoid repeated freeze-thaw cycles by aliquoting the antibody upon receipt. When handling, minimize exposure to light, especially for fluorophore-conjugated antibodies. Most antibodies remain stable in solution containing preservatives like sodium azide (0.02-0.05%), but this may interfere with some enzymatic assays, so consider this in experimental design. Always centrifuge antibody solutions before use to remove aggregates that may affect binding efficiency .

What are the optimal conditions for using SPAC6G9.01c antibodies in Western blotting?

When using SPAC6G9.01c antibodies for Western blotting, optimization is crucial for specific detection. The following protocol has shown reliable results:

• Sample preparation: Lyse S. pombe cells using glass bead disruption in a buffer containing protease inhibitors

• Protein separation: Use 10-12% SDS-PAGE gels for optimal resolution

• Transfer: Semi-dry transfer at 15V for 30 minutes or wet transfer at 100V for 60 minutes

• Blocking: 5% non-fat dry milk in TBST for 1 hour at room temperature

• Primary antibody: Dilute SPAC6G9.01c antibody 1:1000 in blocking buffer and incubate overnight at 4°C

• Washing: 3-4 times with TBST, 5 minutes each

• Secondary antibody: HRP-conjugated secondary at 1:5000 for 1 hour at room temperature

• Detection: ECL substrate with exposure times of 30 seconds to 5 minutes depending on expression levels

This methodology provides consistent detection with minimal background and high specificity for the target protein .

How can I optimize immunoprecipitation experiments using SPAC6G9.01c antibodies?

For successful immunoprecipitation (IP) of SPAC6G9.01c and its interacting partners, consider this methodological approach:

• Pre-clear lysate with protein A/G beads (30 minutes at 4°C) to reduce non-specific binding

• Antibody binding: Incubate 2-5 μg of SPAC6G9.01c antibody with 500-1000 μg of protein lysate for 2-4 hours at 4°C

• Add 30-50 μl of protein A/G beads and incubate overnight at 4°C with gentle rotation

• Wash beads 4-5 times with lysis buffer containing reduced detergent concentration

• Elute bound proteins with either low pH buffer or by boiling in SDS sample buffer

• Analyze by Western blotting or mass spectrometry

For crosslinking IP (ChIP) applications, optimize formaldehyde concentration (0.75-1%) and crosslinking time (10-15 minutes) for S. pombe cells to maintain chromatin integrity while ensuring efficient antibody access to epitopes .

What controls should be included in experiments using SPAC6G9.01c antibodies?

Rigorous experimental design requires appropriate controls when working with SPAC6G9.01c antibodies:

How do post-translational modifications affect SPAC6G9.01c antibody recognition?

Post-translational modifications (PTMs) can significantly impact SPAC6G9.01c antibody recognition and experimental outcomes. Phosphorylation, acetylation, and ubiquitination are common PTMs that may alter epitope accessibility or antibody binding affinity. When selecting antibodies for modified SPAC6G9.01c detection:

• Determine if the antibody epitope overlaps with known or predicted modification sites

• Consider using modification-specific antibodies for targeted PTM detection

• Test antibody performance under different cellular conditions that may alter modification states

• Use phosphatase or deacetylase treatments as controls to confirm modification-dependent recognition

Studies have shown that certain cellular stresses may induce PTMs on SPAC6G9.01c, potentially masking epitopes recognized by commonly used antibodies. When investigating stress responses or cell cycle regulation, consider using multiple antibodies targeting different epitopes to ensure comprehensive protein detection .

What are the best approaches for studying SPAC6G9.01c protein interactions using antibody-based methods?

For investigating SPAC6G9.01c protein interactions, several antibody-based approaches provide complementary information:

• Co-immunoprecipitation (Co-IP): The primary method for detecting stable interactions

  • Use gentle lysis conditions (0.1-0.5% NP-40 or Triton X-100) to preserve complexes

  • Consider crosslinking for transient interactions (DSP or formaldehyde)

  • Elute with gentle conditions to maintain interacting partners

• Proximity Ligation Assay (PLA): For detecting protein proximity in situ

  • Requires antibodies from different species against SPAC6G9.01c and potential interactors

  • Provides spatial information about interactions within cells

  • Can detect interactions that may be lost during traditional IP

• FRET-based immunofluorescence: For studying dynamic interactions

  • Use fluorophore-conjugated antibodies against SPAC6G9.01c and interacting partners

  • Requires optimization of antibody labeling to ensure appropriate fluorophore distances

Each method has distinct advantages, and combining approaches provides the most robust evidence for protein interactions .

How can I quantitatively analyze SPAC6G9.01c expression levels across different experimental conditions?

Quantitative analysis of SPAC6G9.01c expression requires careful methodological consideration:

• Western blot quantification:

  • Use a standard curve of recombinant protein for absolute quantification

  • Ensure linear range of detection with multiple exposures

  • Normalize to loading controls verified to remain constant under your experimental conditions

• ELISA-based quantification:

  • Develop a sandwich ELISA using two antibodies recognizing different epitopes

  • Create a standard curve using purified SPAC6G9.01c protein

  • Validate assay specificity using knockout/deletion samples

• Flow cytometry:

  • Use directly conjugated antibodies for consistent signal

  • Include quantification beads to convert fluorescence to molecules of equivalent soluble fluorochrome (MESF)

  • Validate specificity with competitive binding assays

The table below compares the quantitative precision of different methods:

Each method has specific advantages and limitations that should be considered based on your research questions .

What are common issues with SPAC6G9.01c antibodies and how can they be resolved?

Researchers frequently encounter these challenges when working with SPAC6G9.01c antibodies:

• High background signal:

  • Increase blocking time/concentration (try 5% BSA instead of milk)

  • Use more stringent washing (increase detergent concentration to 0.1-0.2% Tween-20)

  • Titrate antibody to find optimal concentration

  • Pre-absorb antibody with lysate from knockout cells

• Weak or no signal:

  • Verify protein expression under your conditions

  • Test alternative epitope exposure methods (boiling time, detergent type)

  • Try different antibody clones or lots

  • Consider enriching target protein by immunoprecipitation before detection

• Non-specific bands:

  • Validate with knockout/deletion controls

  • Perform peptide competition assays

  • Use more stringent washing conditions

  • Try monoclonal antibodies for higher specificity

• Inconsistent results:

  • Standardize lysate preparation and protein quantification

  • Use internal controls for normalization

  • Prepare larger antibody aliquots to reduce freeze-thaw cycles

  • Consider environmental factors affecting yeast expression

Careful optimization of each experimental step can significantly improve reproducibility and data quality .

How do I interpret contradictory results obtained with different SPAC6G9.01c antibodies?

When different antibodies against SPAC6G9.01c yield contradictory results, systematic analysis helps resolve discrepancies:

• Epitope mapping: Determine if antibodies recognize different regions of the protein

  • Different functional domains may be accessible in different contexts

  • Some epitopes may be masked by protein interactions or conformational changes

  • Post-translational modifications might affect epitope recognition

• Validation methods comparison:

  • Compare knockout/deletion controls across antibodies

  • Test all antibodies against recombinant protein and immunodepleted samples

  • Assess cross-reactivity with closely related proteins

• Technical validation:

  • Standardize experimental conditions when comparing antibodies

  • Consider fixation effects on epitope accessibility (for microscopy)

  • Test multiple lots of each antibody for consistency

• Biological interpretation:

  • Different results may reflect biological reality (protein isoforms, modifications)

  • Combine multiple detection methods (WB, IP, IF) to build comprehensive understanding

  • Consider context-dependent protein behaviors (stress, cell cycle stage, etc.)

Contradictory results often reveal important biological insights when systematically investigated rather than simply discarded as technical failures .

What statistical approaches are recommended for analyzing SPAC6G9.01c quantification data?

Robust statistical analysis of SPAC6G9.01c quantification requires approaches tailored to antibody-based detection methods:

• For Western blot densitometry:

  • Use biological replicates (n≥3) rather than technical replicates

  • Apply appropriate normalization to account for loading variations

  • Test for normal distribution before selecting parametric/non-parametric tests

  • Consider log transformation for wide expression ranges

• For microscopy quantification:

  • Define objective criteria for image analysis before data collection

  • Analyze sufficient cell numbers for statistical power (typically >100 cells)

  • Use nested statistical models to account for within/between sample variation

  • Consider photobleaching effects in time-course experiments

• General statistical considerations:

  • Use ANOVA with appropriate post-hoc tests for multiple condition comparisons

  • Report effect sizes alongside p-values

  • Consider false discovery rate correction for multiple comparisons

  • Validate findings with orthogonal methods

The table below summarizes statistical approaches for different experimental designs:

How can SPAC6G9.01c antibodies be used in combination with CRISPR-Cas9 gene editing?

CRISPR-Cas9 technology offers powerful approaches for studying SPAC6G9.01c when combined with antibody-based detection:

• Endogenous tagging verification:

  • Use CRISPR to introduce epitope tags into the SPAC6G9.01c locus

  • Verify correct integration using antibodies against both SPAC6G9.01c and the tag

  • Compare localization patterns between tagged and untagged protein

• Knockout validation strategies:

  • Generate CRISPR knockouts of SPAC6G9.01c

  • Use these knockouts as definitive negative controls for antibody specificity

  • Employ antibodies to confirm complete protein loss in knockout lines

• Domain-specific function analysis:

  • Create domain-specific mutations or truncations via CRISPR

  • Use domain-specific antibodies to assess effects on protein stability and localization

  • Combine with interaction studies to map functional regions

• Inducible expression systems:

  • Engineer CRISPR-based inducible expression of SPAC6G9.01c variants

  • Use antibodies to measure expression kinetics and dose-response relationships

  • Quantify effects on downstream pathways using phospho-specific antibodies

This integration of genetic engineering with antibody-based detection provides multidimensional insights into SPAC6G9.01c function that neither approach alone can achieve .

What are the considerations for using SPAC6G9.01c antibodies in super-resolution microscopy?

Super-resolution microscopy techniques offer nanoscale visualization of SPAC6G9.01c localization and interactions, but require specific antibody considerations:

• Antibody selection for different super-resolution methods:

  • STED: Use bright, photostable fluorophores (Alexa 594, STAR 635P)

  • STORM/PALM: Consider photoconvertible fluorophore conjugates

  • SIM: Standard high-quality IF antibodies are usually sufficient

• Critical optimization parameters:

  • Fixation methods significantly impact epitope preservation and structure

  • Test multiple fixatives (PFA, methanol, glyoxal) for optimal signal-to-noise

  • Reduce background through extensive blocking and washing steps

  • Consider smaller detection probes (Fab fragments, nanobodies) for improved resolution

• Validation approaches:

  • Compare multiple antibodies recognizing different epitopes

  • Correlate with electron microscopy for structural context

  • Use biological perturbations with predictable localization changes as controls

• Quantitative considerations:

  • Establish stringent criteria for quantifying clusters or co-localization

  • Consider molecule counting approaches for quantitative analysis

  • Use appropriate controls for cluster analysis algorithms

Super-resolution approaches have revealed previously undetected subcellular distributions of proteins in yeast that were obscured in conventional microscopy, potentially offering new insights into SPAC6G9.01c function .

What emerging antibody technologies might enhance SPAC6G9.01c research?

Several cutting-edge technologies are poised to transform SPAC6G9.01c antibody-based research:

• Single-domain antibodies (nanobodies):

  • Smaller size allows access to sterically hindered epitopes

  • Improved penetration in fixed samples for microscopy

  • Potential for intracellular expression as functional inhibitors

• Recombinant renewable antibodies:

  • Consistent performance across batches eliminates lot-to-lot variation

  • Engineered affinity and specificity for challenging applications

  • Possibility of rational design for specific functional domains

• Multiplexed detection systems:

  • Mass cytometry (CyTOF) using metal-labeled antibodies

  • Multiplexed immunofluorescence with spectral unmixing

  • Sequential detection cycles for highly multiplexed imaging

• Synthetic biology approaches:

  • Split-protein complementation assays using antibody fragments

  • Optogenetic control of antibody-based detection systems

  • Cell-free expression systems for rapid antibody engineering

These emerging technologies will likely overcome current limitations in studying dynamic processes and rare populations involving SPAC6G9.01c in various cellular contexts .

How might understanding SPAC6G9.01c contribute to broader research in model organisms?

SPAC6G9.01c research has implications that extend beyond S. pombe to other model systems and potentially human biology: